What is the current Price Target for the Tenaya Therapeutics Inc stock?

The average Tenaya Therapeutics Inc target price is $10.14. This is 2,012.66% higher than the current stock price. The highest price target is 8,231.60%, the lowest is 524.87%. 7 Analysts have issued a price target Tenaya Therapeutics Inc 2026 .

How high will the Tenaya Therapeutics Inc stock rise?

No reliable answer can be given as to how high the Tenaya Therapeutics Inc stock will rise. The performance of stocks, including the Tenaya Therapeutics Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Tenaya Therapeutics Inc stock today?

The performance of Tenaya Therapeutics Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Tenaya Therapeutics Inc stock fall?

The decline in Tenaya Therapeutics Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Tenaya Therapeutics Inc Forecast, price target & analysts

$0.49

2.17% yesterday

Nasdaq, Apr 07, 09:50 pm CET

ISIN

US87990A1060

Symbol

TNYA

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Tenaya Therapeutics Inc Target price 2025 - Analyst rating & recommendation

Tenaya Therapeutics Inc Classifications & Recommendation:

Buy

100%

Tenaya Therapeutics Inc Price Target

Target Price	$10.14
Price	$0.48
Potential	2,012.66% register free of charge
Number of Estimates	7

	7 Analysts have issued a price target Tenaya Therapeutics Inc 2026 . The average Tenaya Therapeutics Inc target price is $10.14. This is 2,012.66% register free of charge higher than the current stock price. The highest price target is $40.00 8,231.60% register free of charge , the lowest is $3.00 524.87% register free of charge .
	A rating was issued by 9 analysts: 9 Analysts recommend Tenaya Therapeutics Inc to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Tenaya Therapeutics Inc stock has an average upside potential 2026 of 2,012.66% register free of charge . Most analysts recommend the Tenaya Therapeutics Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-1.31	-0.51
	22.02%	61.07%
P/E		negative
EV/Sales		14.10

1 Analysts have issued a Tenaya Therapeutics Inc forecast for earnings per share. The average Tenaya Therapeutics Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-1.31	22.02%
2025	$-0.51 61.07% Unlock
2026	$-0.55 7.84% Unlock
2027	$-0.48 12.73% Unlock
2028	$0.85 277.08% Unlock
2029	$2.47 190.59% Unlock

Current	-0.37	86.45%
2025	-0.94 154.05% Unlock
2026	-0.87 7.45% Unlock
2027	-1.00 14.94% Unlock
2028	0.56 156.00% Unlock
2029	0.19 66.07% Unlock

Tenaya Therapeutics Inc...

Current Tenaya Therapeutics Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 31 2025
Canaccord Genuity	Locked ➜ Locked	Locked	Mar 13 2025
Chardan Capital	Locked ➜ Locked	Locked	Mar 12 2025
Morgan Stanley	Locked ➜ Locked	Locked	Mar 12 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 11 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Feb 03 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jan 14 2025

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 31 2025
Locked Canaccord Genuity: Locked ➜ Locked	Mar 13 2025
Locked Chardan Capital: Locked ➜ Locked	Mar 12 2025
Locked Morgan Stanley: Locked ➜ Locked	Mar 12 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 11 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Feb 03 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Jan 14 2025

Discover more stocks with a high price target

MongoDB 96.77%

Coinbase Global, Inc. 95.22%

BioNTech SE - ADR 59.48%

Snowflake 58.39%

Alibaba Group Holding Ltd 58.36%

PayPal 58.24%

NIO ADR 57.59%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now